Current Treatments

• Surgery - the first step in treating any GIST, whenever possible.
• Post-Surgery Preventive Imatinib (Gleevec) - being studied in trials to determine whether it will prevent recurrence.
• Imatinib (Gleevec) - FDA-approved for unresectable and metastatic GIST.
• Sunitinib (Sutent) - FDA-approved for GIST resistant to imatinib/Gleevec and for patients who are intolerant of imatinib/Gleevec.
• Hepatic artery embolization - a surgical procedure for liver metastases.
• Radiofrequency ablation - a surgical procedure for liver metastases.
• Current Treatment Directions - overview and list of consensus documents

• GIST Patients' Right to Treatment - the Bad Nauheim Declaration, endorsed by GIST Support International, for the right of all GIST patients to receive up-to-date treatment.

Emerging Treatments

• Emerging Treatments covers drugs in pre-clinical development and in clinical trials.

Clinical Trials

• Clinical Trials informs you about current trials for gastrointestinal stromal tumor plus things to consider before signing up for a trial.